Francisco J. Puga mostly deals with Surgery, Cardiology, Internal medicine, Aortic valve and Survival rate. His study in Surgery is interdisciplinary in nature, drawing from both Fontan procedure, Heart disease and Valve replacement. Pulmonary artery, Pulmonary valve, Aortic valve replacement, Warfarin and Tricuspid atresia are the core of his Cardiology study.
Internal medicine is closely attributed to Surgical repair in his research. His Aortic valve research integrates issues from Mitral valve, Thorax and Benign tumor. Francisco J. Puga studied Survival rate and Aorta that intersect with Radiology.
His primary areas of investigation include Surgery, Internal medicine, Cardiology, Heart disease and Pulmonary artery. His research integrates issues of Fontan procedure and Stenosis in his study of Surgery. His Artery, Mitral valve replacement, Tricuspid atresia and Cardiac catheterization study, which is part of a larger body of work in Internal medicine, is frequently linked to In patient, bridging the gap between disciplines.
His biological study spans a wide range of topics, including Survival rate and Aortic valve replacement. His studies in Heart disease integrate themes in fields like Atrioventricular valve and El Niño. His work deals with themes such as Hemodynamics and Blood vessel prosthesis, which intersect with Pulmonary artery.
His main research concerns Surgery, Cardiology, Internal medicine, Heart disease and Cardiopulmonary bypass. His research brings together the fields of Stroke and Surgery. His study explores the link between Cardiology and topics such as Vascular disease that cross with problems in Median sternotomy, Endocarditis and Perioperative.
His Heart disease research incorporates themes from Heart septal defect, Constrictive pericarditis, Planned procedure and Cardiac operations. The Cardiopulmonary bypass study combines topics in areas such as Mortality rate, Cardiac surgery and Heart-Lung Machine. The study incorporates disciplines such as Ventricle and Transplantation in addition to Tricuspid valve.
His primary scientific interests are in Surgery, Cardiology, Internal medicine, Aortic valve and Retrospective cohort study. His study in the field of Thorax also crosses realms of Population. Francisco J. Puga usually deals with Cardiology and limits it to topics linked to Odds ratio and Prosthesis, Risk factor, Myocardial infarction, Mitral valve replacement and Mitral valve.
His Aortic valve research includes elements of Artery, Aortic valve repair and Warfarin. His Retrospective cohort study study combines topics from a wide range of disciplines, such as Aneurysm, Aorta, Confidence interval, Perioperative and Marfan syndrome. His Fontan procedure study integrates concerns from other disciplines, such as Pleural effusion, Quality of life, Anastomosis and Tricuspid atresia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years
Joseph G. Murphy;Bernard J. Gersh;Michael D. McGoon;Douglas D. Mair.
The New England Journal of Medicine (1990)
Five- to fifteen-year follow-up after Fontan operation.
David J. Driscoll;Kenneth P. Offord;Robert H. Feldt;Hartzell V Schaff.
A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass Operations: Benefit of Perioperative Dipyridamole and Aspirin Therapy on Early Postoperative Vein-Graft Patency
J. H. Chesebro;I. P. Clements;V. Fuster;L. R. Elveback.
The New England Journal of Medicine (1982)
Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations
James H. Chesebro;Valentin Fuster;Lila R. Elveback;Ian P. Clements.
The New England Journal of Medicine (1984)
Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamole
James H Chesebro;Valentin Fuster;Lila R Elveback;Dwight C McGoon.
American Journal of Cardiology (1983)
Protein-losing enteropathy after the Fontan operation.
Robert H. Feldt;David J. Driscoll;Kenneth P. Offord;Ruth H. Cha.
The Journal of Thoracic and Cardiovascular Surgery (1996)
High risk of thromboemboli early after bioprosthetic cardiac valve replacement
Magda Heras;James H. Chesebro;Valentin Fuster;William J. Penny.
Journal of the American College of Cardiology (1995)
Late pulmonary valve replacement after repair of tetralogy of Fallot
Berent Discigil;Joseph A. Dearani;Francisco J. Puga;Hartzell V. Schaff.
The Journal of Thoracic and Cardiovascular Surgery (2001)
Surgical Patent Foramen Ovale Closure for Prevention of Paradoxical Embolism–Related Cerebrovascular Ischemic Events
Joseph A. Dearani;Baran S. Ugurlu;Gordon K. Danielson;Richard C. Daly.
Survival after resection of primary cardiac tumors: a 48-year experience.
Andrew W. ElBardissi;Joseph A. Dearani;Richard C. Daly;Charles J. Mullany.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: